Azimuth Capital Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Azimuth Capital Investment Management's AMGN Position: Q1 2026 in Review
Azimuth Capital Investment Management increased its Amgen (AMGN) stake by 0.67% in Q1 2026, buying an estimated $43.5K and bringing the position to 18,265 shares worth $6.43M. The position accounts for 0.24% of the portfolio, ranked #129.
Azimuth Capital Investment Management first reported a position in AMGN in Q2 2022 and has held it in 16 quarters since. The position peaked at $8.08M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Azimuth Capital Investment Management held 18,265 shares of Amgen worth $6.43M as of Q1 2026.
- Azimuth Capital Investment Management bought 122 Amgen shares in Q1 2026, an estimated $43.5K.
- Amgen made up 0.24% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #129 holding.
- Azimuth Capital Investment Management first reported a position in Amgen in Q2 2022 and has held it in 16 quarters since.
- Azimuth Capital Investment Management's Amgen position peaked at $8.08M in Q3 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.